EMBC
Embecta Corp.
EMBC's fundamentals are mixed, but it looks cheap: trading at 4.4x earnings, less than half its usual 11x. Analysts expect earnings growth, though they disagree widely on how much.
EMBC Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Strong | |
| Weak |
EMBC's profitability and cash flow are currently healthy, but its revenue and balance sheet are under pressure.
EMBC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.6x | $6.43 | — |
| Cheap | 4.2x | $6.18 | -3.9% |
| Current | 4.4x | $6.43 | — |
| Fair | 11x | $16.52 | +157% |
| Expensive | 15x | $22.04 | +243% |
Historical ranges are pointers, not guarantees.
EMBC's PE is in its cheap range at 4.4x. If earnings grow as analysts expect, today's price would be 3.6x next year's earnings.
EMBC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect EMBC's earnings to grow, with its revenue and profitability holding steady. However, they disagree widely on these estimates.
EMBC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.81 | +23% |
| Q2 2026 | $1.47 | +3.5% |
| Q1 2026 | $1.89 | +112% |
| Q4 2025 | $2.36 | +138% |
| Q3 2025 | $1.62 | +21% |
| Q2 2025 | $1.42 | +17% |
| Q1 2025 | $0.89 | -27% |
| Q4 2024 | $0.99 | +3.1% |
| Q3 2024 | $1.34 | +9.8% |
EMBC's earnings per share have fallen from their peak: $1.47 over the past year, against $7.28 in late 2021.
EMBC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $271.7M | -8.1% |
| Q1 2026 | $221.8M | -14% |
| Q4 2025 | $261.2M | -0.3% |
| Q3 2025 | $264M | -7.7% |
| Q2 2025 | $295.5M | +8.4% |
| Q1 2025 | $259M | -9.8% |
| Q4 2024 | $261.9M | -5.6% |
| Q3 2024 | $286.1M | +1.5% |
EMBC's revenue is shrinking: $272M last quarter, down 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 18% | -14 points |
| Q1 2026 | 16% | -8.5 points |
| Q4 2025 | 32% | +21 points |
| Q3 2025 | 21% | +12 points |
| Q2 2025 | 32% | +11 points |
| Q1 2025 | 24% | +11 points |
| Q4 2024 | 11% | -5.4 points |
| Q3 2024 | 9.2% | 0 points |
EMBC's operating margin was 18% last quarter, down 14 points from the same quarter a year ago.
EMBC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $40.7M | -50% |
| Q1 2026 | $30.6M | -3.5% |
| Q4 2025 | $16.6M | +$23.4M |
| Q3 2025 | $76.7M | +188% |
| Q2 2025 | $80.8M | +$92.6M |
| Q1 2025 | $31.7M | +52% |
| Q4 2024 | -$6.8M | +$9M |
| Q3 2024 | $26.6M | +30% |
EMBC still generates free cash flow, though less than at its 2022 peak: $165M over the past year.
EMBC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -787K shares |
| 1 year | 0% | +17K shares |
| 3 years | +1.6% | +930K shares |
| 5 years | +2.7% | +1.5M shares |
EMBC has 59M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
EMBC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.6x | High |
| Q1 2026 | 3.7x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.2x | High |
| Q2 2025 | 5.0x | High |
| Q1 2025 | 6.2x | High |
| Q4 2024 | 7.1x | High |
| Q3 2024 | 6.4x | High |
EMBC's net debt is about 4.6 years of its operating earnings (EBITDA), down from 5.0 years a year ago.
EMBC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.7 | Neutral |
| Stochastic | 81.2 | Overbought |
EMBC's weekly RSI is 55 (neutral) and its Stochastic is 81 (overbought).
EMBC PE vs Healthcare Sector
| Metric | EMBC | Sector median | Relative |
|---|---|---|---|
| PE | 4.4x | 26x | 83% below |
| PE % | 19 | 43 | 24 pts below |
EMBC is trading at 4.4x earnings, a 83% discount to the Healthcare sector's median of 26x.
EMBC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.14 | 4.7% above |
| 20 week MA | $5.08 | 27% above |
| 50 week MA | $7.14 | 9.9% below |
| 100 week MA | $10.4 | 38% below |
| 200 week MA | $14.4 | 55% below |
EMBC has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 55% below its 200-week average.
EMBC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $43.0 | $27.5 | -36% |
| 2023 | $27.5 | $18.9 | -31% |
| 2024 | $18.9 | $20.7 | +9.4% |
| 2025 | $20.7 | $12.0 | -42% |
| 2026 YTD | $12.0 | $6.43 | -46% |
EMBC has finished lower in three of the last four years. It's down 46% so far in 2026.